On the positive side, let's hope the 'revelation' is near. The 'revelation' must be dramatic and strong. Having said that, this continues to be one of a 'thousand cuts' that makes retail investors become cynical. Certainly these 'private' offerings seem to have the slant that they wouldn't invest millions unless they saw (greedy) opportunity and the end of the tunnel. This isn't the first time, insiders or 'institutional investors' have bought into RCPI and lost. What bothers me at this point are the following:
1. If Anatabine Citrate is so great like so many of us think it is, why hasn't any outside Big Pharma shown any interest? With presentations at professional conferences, seems like no one is interested (financially). (that we know of)
2. If Anatabine Citrate has the potential most of us feel it has, why does the management keep nickle and diming funding to keep it alive for the next 6 months to a year. (driving the stock even lower) Why don't they do like others and go with a HUGE IPO in the magnitude of several million dollars? Other small biotech seem to be able to do this with much less to offer.
3. More and more interest in 'chronic inflammation' is making it's way into the public eye but no one has yet to declare decisively that this is the 'holy grail' to solving many of the aging diseases that afflict we humans.
When and if a 'profound' announcement is made that will cause the stock to significantly rise and put doubters to rest, we have only two choices: hang on for that great day or capitulate and move on. I'm of the opinion that in some near future, breaktrhoughs will come with proof of performance for compounds like Anatabine Citrate, the big question is whether RCPI will be chosen when that day comes?
News 
Market Data 
Discover 
